LifeNet Health Advances Regenerative Medicine with the Acquisition of Biopreservation Leader, Tissue Testing Technologies
LifeNet Health Advances Regenerative Medicine with the Acquisition of Biopreservation Leader, Tissue Testing Technologies
December 15, 2025 – Virginia Beach, VA and Charleston, SC – LifeNet Health, a global leader in regenerative medicine, has acquired Tissue Testing Technologies LLC (T3), a biotechnology company specializing in biopreservation. T3 ‘s advanced proprietary technologies and services preserve living cells and tissues for clinical and research applications, ensuring the quality and impact of life-saving therapies.